SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-12-002472
Filing Date
2012-08-07
Accepted
2012-08-07 17:29:53
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063012.htm 10-Q 824599
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 18792
3 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 19178
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 8643
5 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER ex32_2.htm EX-32.2 8549
  Complete submission text file 0001387131-12-002472.txt   4131344

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20120630.xml EX-101.INS 582229
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20120630.xsd EX-101.SCH 36083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENTXBRL TAXONOMY EXTENSION CAL ohrp-20120630_cal.xml EX-101.CAL 34103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20120630_def.xml EX-101.DEF 88225
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20120630_lab.xml EX-101.LAB 246448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20120630_pre.xml EX-101.PRE 158055
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-88480 | Film No.: 121014448
SIC: 2834 Pharmaceutical Preparations